Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Daniel

Showing results (11-20 of 196) with videos related to

Pageof 20
Sort By:
Frontiers in Psychology|March 10, 2023
Editorial: Ageing and migration status: Intersectional forms of discrimination and exclusionMatt Flynn, Petia Genkova, Elaine Dewhurst, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 6, 2004
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1Christoph Daniel, Jeffrey Pippin, Stuart J Shankland, et al.
International Journal of Nephrology|September 7, 2018
Vascular Calcification in Chronic Kidney Disease: The Role of InflammationKerstin Benz, Karl-Friedrich Hilgers, Christoph Daniel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db miceIvonne Loeffler, Marita Liebisch, Christoph Daniel, et al.
Diabetes|September 20, 2007
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivoChristoph Daniel, Kathrin Schaub, Kerstin Amann, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2007
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in miceChristoph Daniel, Kerstin Amann, Bernd Hohenstein, et al.
Transplantation|December 20, 2007
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the ratRegina Vogelbacher, Sandra Wittmann, Andrea Braun, et al.
Frontiers in Cardiovascular Medicine|July 17, 2023
Experimental renal transplantation in rats improves cardiac dysfunction caused by chronic kidney disease while LVH persistsLinda Hagmayer, Christina Mayer, Nadja Ebert, et al.
Environmental Science. Processes & Impacts|June 18, 2016
No measurable "cleaning" of polychlorinated biphenyls from Rainbow Trout in a 9 week depuration study with dietary exposure to 40% polyethylene microspheresChristoph Daniel Rummel, Margaretha Adolfsson-Erici, Annika Jahnke, et al.
Plos One|December 31, 2013
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyChristoph Daniel, Regina Vogelbacher, Andrea Stief, et al.
Pageof 20

Showing results (11-20 of 196) with videos related to

Sort By:
Pageof 20
Frontiers in Psychology|March 10, 2023
Editorial: Ageing and migration status: Intersectional forms of discrimination and exclusionMatt Flynn, Petia Genkova, Elaine Dewhurst, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 6, 2004
The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1Christoph Daniel, Jeffrey Pippin, Stuart J Shankland, et al.
International Journal of Nephrology|September 7, 2018
Vascular Calcification in Chronic Kidney Disease: The Role of InflammationKerstin Benz, Karl-Friedrich Hilgers, Christoph Daniel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 10, 2017
Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db miceIvonne Loeffler, Marita Liebisch, Christoph Daniel, et al.
Diabetes|September 20, 2007
Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivoChristoph Daniel, Kathrin Schaub, Kerstin Amann, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2007
Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in miceChristoph Daniel, Kerstin Amann, Bernd Hohenstein, et al.
Transplantation|December 20, 2007
The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the ratRegina Vogelbacher, Sandra Wittmann, Andrea Braun, et al.
Frontiers in Cardiovascular Medicine|July 17, 2023
Experimental renal transplantation in rats improves cardiac dysfunction caused by chronic kidney disease while LVH persistsLinda Hagmayer, Christina Mayer, Nadja Ebert, et al.
Environmental Science. Processes & Impacts|June 18, 2016
No measurable "cleaning" of polychlorinated biphenyls from Rainbow Trout in a 9 week depuration study with dietary exposure to 40% polyethylene microspheresChristoph Daniel Rummel, Margaretha Adolfsson-Erici, Annika Jahnke, et al.
Plos One|December 31, 2013
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathyChristoph Daniel, Regina Vogelbacher, Andrea Stief, et al.
Pageof 20